Danske Bank’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.1M Buy
52,242
+4,040
+8% +$1.25M 0.03% 362
2026
Q2
$13.5M Buy
48,202
+9,500
+25% +$2.5M 0.03% 400
2026
Q1
$10.3M Sell
38,702
-2,900
-7% -$785K 0.02% 426
2025
Q4
$10.4M Buy
41,602
+6,080
+17% +$1.61M 0.02% 438
2025
Q3
$10.2M Sell
35,522
-11,866
-25% -$3.18M 0.03% 434
2025
Q2
$12.4M Buy
47,388
+4,868
+11% +$1.19M 0.03% 389
2025
Q1
$9.9M Sell
42,520
-2,068
-5% -$502K 0.03% 410
2024
Q4
$10.2M Buy
44,588
+10,168
+30% +$2.33M 0.03% 404
2024
Q3
$7.69M Sell
34,420
-400
-1% -$87.9K 0.03% 456
2024
Q2
$7.09M Sell
34,820
-4,900
-12% -$997K 0.03% 443
2024
Q1
$8.68M Buy
+39,720
New +$8.75M 0.03% 449

Other funds holding LH

Danske Bank's LH Position: Q3 2026 in Review

Danske Bank increased its Labcorp (LH) stake by 8.4% in Q3 2026, buying an estimated $1.25M and bringing the position to 52,242 shares worth $16.1M. The position accounts for 0.03% of the portfolio, ranked #362.

Danske Bank first reported a position in LH in Q1 2024 and has held it in 11 quarters since. 1,042 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Danske Bank held 52,242 shares of Labcorp worth $16.1M as of Q3 2026.
  • Danske Bank bought 4,040 Labcorp shares in Q3 2026, an estimated $1.25M.
  • Labcorp made up 0.03% of Danske Bank's portfolio in Q3 2026, its #362 holding.
  • Danske Bank first reported a position in Labcorp in Q1 2024 and has held it in 11 quarters since.
  • 1,042 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.